These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue. Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857 [TBL] [Abstract][Full Text] [Related]
9. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma. Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566 [TBL] [Abstract][Full Text] [Related]
10. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Gardner SL; Asgharzadeh S; Green A; Horn B; McCowage G; Finlay J Pediatr Blood Cancer; 2008 Aug; 51(2):235-40. PubMed ID: 18381756 [TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy with autologous stem-cell rescue in children and adults with newly diagnosed pineoblastomas. Gururangan S; McLaughlin C; Quinn J; Rich J; Reardon D; Halperin EC; Herndon J; Fuchs H; George T; Provenzale J; Watral M; McLendon RE; Friedman A; Friedman HS; Kurtzberg J; Vredenbergh J; Martin PL J Clin Oncol; 2003 Jun; 21(11):2187-91. PubMed ID: 12775745 [TBL] [Abstract][Full Text] [Related]
12. Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation. Stewart DA; Guo D; Glück S; Morris D; Chaudhry A; deMetz C; Klassen J; Brown CB; Russell JA Bone Marrow Transplant; 2000 Aug; 26(4):383-8. PubMed ID: 10982284 [TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma. Kremens B; Wieland R; Reinhard H; Neubert D; Beck JD; Klingebiel T; Bornfeld N; Havers W Bone Marrow Transplant; 2003 Feb; 31(4):281-4. PubMed ID: 12621463 [TBL] [Abstract][Full Text] [Related]
15. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience. Fangusaro J; Finlay J; Sposto R; Ji L; Saly M; Zacharoulis S; Asgharzadeh S; Abromowitch M; Olshefski R; Halpern S; Dubowy R; Comito M; Diez B; Kellie S; Hukin J; Rosenblum M; Dunkel I; Miller DC; Allen J; Gardner S Pediatr Blood Cancer; 2008 Feb; 50(2):312-8. PubMed ID: 17668858 [TBL] [Abstract][Full Text] [Related]
17. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996]. Fléchon A; Biron P; Philip I; Blay JY; Droz JP Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344 [TBL] [Abstract][Full Text] [Related]
18. Thiotepa/topotecan/carboplatin with autologous stem cell rescue in recurrent/refractory/poor prognosis pediatric malignancies of the central nervous system. Gilheeney SW; Khakoo Y; Souweidane M; Wolden S; Boulad F; Dunkel IJ Pediatr Blood Cancer; 2010 Apr; 54(4):591-5. PubMed ID: 19998470 [TBL] [Abstract][Full Text] [Related]
19. Successful treatment of trilateral retinoblastoma with conventional and high-dose chemotherapy plus radiotherapy: a case report. De Ioris MA; Fidani P; Munier FL; Serra A; Ilari I; Popovic MB; Natali G; Secco DE; Cozza R J Pediatr Hematol Oncol; 2010 Nov; 32(8):e343-5. PubMed ID: 20881869 [TBL] [Abstract][Full Text] [Related]
20. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer. Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]